The patient has been advised to continue with pharmacologic therapy, including beta-blockers and angiotensin-converting enzyme inhibitors (ACE inhibitors), to manage heart failure and prevent any potential deterioration in cardiac function. This evidence concerns the gene ACE and heart failure.